Burcon NutraScience's earnings before interest and taxes (EBIT) for the
three
months ended in Mar. 2026 was $-2.23 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-8.19 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Burcon NutraScience's annualizedROC % for the quarter that ended in Mar. 2026 was -42.45%.
Burcon NutraScience's annualizedROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -87.08%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Burcon NutraScience's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -24.51%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Burcon NutraScience's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Burcon NutraScience EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Burcon NutraScience's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Burcon NutraScience's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Burcon NutraScience (BRCNF) has a EBIT of $-8.19 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Burcon NutraScience.
Is Burcon NutraScience's EBIT too high?
Burcon NutraScience's current EBIT is $-8.19 Mil. Overall, Burcon NutraScience has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Burcon NutraScience's EBIT compare to KHC and GIS?
Burcon NutraScience's EBIT of $-8.19 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Burcon NutraScience. Burcon NutraScience's current EBIT is $-8.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burcon NutraScience stock overvalued right now?
Based on GuruFocus' analysis, Burcon NutraScience (BRCNF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.35, compared to a current price of $1.37 — trading 74.4% below its estimated fair value. The current EBIT is $-8.19 Mil. Burcon NutraScience's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Burcon NutraScience (BRCNF), the current EBIT is $-8.19 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Burcon NutraScience (BRCNF) Overvalued in 2026?
Based on GuruFocus' analysis, Burcon NutraScience stock appears to be undervalued.
The current stock price of $1.37 is trading 74.4% below its estimated GF Value™ of $5.35.
GuruFocus considers Burcon NutraScience to be Possible Value Trap.
Key valuation signals for BRCNF:
EBIT: $-8.19 Mil
GF Value™: $5.35 vs. price of $1.37 (74.4% below fair value)
No single metric tells the full story. See the BRCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Burcon NutraScience Corp is a technology company in the development of plant-based proteins. With several issued patent applications, that have been developed, Burcon has grown a portfolio of composition, application, and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed, and more. Its joint venture Merit Foods is building a protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients.
48GF Score
Get the complete analysis for BRCNF
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRCNF has been successfully added to your 
